Neuronal properties, in vivo effects, and pathology of a Huntington's disease patient-derived induced pluripotent stem cells (Q38462208)

3 September 2017

title

Neuronal properties, in vivo effects, and pathology of a Huntington's disease patient-derived induced pluripotent stem cells (English)

1 reference

3 September 2017

0 references

0 references

1 reference

George Q Daley

0 references

Jia-Yi Li

0 references

Dong Ah Shin

0 references

Patrik Brundin

1 reference

3 September 2017

In-Hyun Park

1 reference

3 September 2017

Dong Ryul Lee

1 reference

3 September 2017

Manho Kim

1 reference

3 September 2017

Nayeon Lee

1 reference

3 September 2017

Chunggab Choi

1 reference

3 September 2017

Iksoo Jeon

1 reference

3 September 2017

Jihye Kwon

1 reference

3 September 2017

Kyoung Sun Park

1 reference

3 September 2017

Jisook Moon

1 reference

3 September 2017

Sung Han Shim

1 reference

3 September 2017

Da-Jeong Chang

1 reference

3 September 2017

Seung-Hun Oh

1 reference

3 September 2017

Hyun Sook Kim

1 reference

3 September 2017

Jeong Tae Do

1 reference

3 September 2017

Kyung-Sun Kang

1 reference

3 September 2017

Jihwan Song

1 reference

3 September 2017

language of work or name

English

0 references

publication date

1 September 2012

1 reference

3 September 2017

1 reference

3 September 2017

1 reference

3 September 2017

1 reference

3 September 2017

page(s)

2054-2062

1 reference

Medium spiny neurons for transplantation in Huntington's disease

3 September 2017

cites work

1 reference

Motor and cognitive improvements in patients with Huntington's disease after neural transplantation

21 January 2018

1 reference

Unilateral transplantation of human primary fetal tissue in four patients with Huntington's disease: NEST-UK safety report ISRCTN no 36485475.

21 January 2018

1 reference

Human striatal neuroblasts develop and build a striatal-like structure into the brain of Huntington's disease patients after transplantation

21 January 2018

1 reference

Cell replacement therapies for central nervous system disorders.

21 January 2018

1 reference

Stem cell transplantation for Huntington's disease.

21 January 2018

1 reference

Disease-specific induced pluripotent stem cells

21 January 2018

1 reference

Generation of human-induced pluripotent stem cells

21 January 2018

1 reference

Induction of midbrain dopaminergic neurons from ES cells by stromal cell-derived inducing activity.

21 January 2018

1 reference

Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat.

21 January 2018

1 reference

The "staircase test": a measure of independent forelimb reaching and grasping abilities in rats

21 January 2018

1 reference

Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system.

21 January 2018

1 reference

Directed differentiation of dopaminergic neuronal subtypes from human embryonic stem cells.

21 January 2018

1 reference

A multitarget basal ganglia dopaminergic and GABAergic transplantation strategy enhances behavioural recovery in parkinsonian rats

21 January 2018

1 reference

miR-371-3 expression predicts neural differentiation propensity in human pluripotent stem cells.

21 January 2018

1 reference

Striatal progenitors derived from human ES cells mature into DARPP32 neurons in vitro and in quinolinic acid-lesioned rats.

21 January 2018

1 reference

Human embryonic stem cell-derived GABA neurons correct locomotion deficits in quinolinic acid-lesioned mice.

21 January 2018

1 reference

DARPP-32-rich zones in grafts of lateral ganglionic eminence govern the extent of functional recovery in skilled paw reaching in an animal model of Huntington's disease

21 January 2018

1 reference

A comparative study of preparation techniques for improving the viability of striatal grafts using vital stains, in vitro cultures, and in vivo grafts

21 January 2018

1 reference

A huntingtin-associated protein enriched in brain with implications for pathology

21 January 2018

1 reference

Characterization of Human Huntington's Disease Cell Model from Induced Pluripotent Stem Cells

21 January 2018

1 reference

The first reported generation of several induced pluripotent stem cell lines from homozygous and heterozygous Huntington's disease patients demonstrates mutation related enhanced lysosomal activity

21 January 2018

1 reference

Gene targeting of a disease-related gene in human induced pluripotent stem and embryonic stem cells

21 January 2018

1 reference

Examination of mesenchymal stem cell-mediated RNAi transfer to Huntington's disease affected neuronal cells for reduction of huntingtin

21 January 2018

1 reference

Genetically engineered mesenchymal stem cells as a proposed therapeutic for Huntington's disease

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/STEM.1135

1 reference

3 September 2017

1 reference